SLC9A6 and metabolic dysfunction-associated steatotic liver disease: Our results elucidate for the first time the pathogenic mechanism of circ‐SLC9A6‐encoded SLC9A6‐126aa, which could be an effective diagnostic marker and therapeutic target for NAFLD.